Brain Monitoring Devices Global Market-Forecast to 2026

Publishing Date :	July, 2020
Report Code :	HCMD0144
Price:	Single license $4,950 Site license $6,750 Global license $9,000

Note: The report would be dispatched after confirmation of payment

Brain monitoring devices are used to monitor the electrical and neuronal activity of the patient’s head which helps to diagnose various neuronal conditions, sleep disorders, brain tumors, and others. The brain monitoring devices market is expected to grow at mid single digit CAGR of from 2019 to 2026 to reach $8,855.9 million by 2026. Growing incidence and prevalence of neurological disorders, rising awareness about neurodegenerative disorders, growing healthcare spending in brain monitoring are driving the market growth. However, the high cost of complex brain monitoring devices, lack of skilled neurologists and neurosurgeons, stringent regulatory approvals for products, unfavorable reimbursement policies are restraining the market growth.

The brain monitoring devices global market segmented based on products, applications, modality, and end-users. The market by product is segmented into electroencephalography (EEG), magnetoencephalography (MEG), Intracranial Pressure (ICP) monitors, Transcranial Doppler Sonography (TCD), Electromyograph (EMG), Cerebral Oximeters, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), and sleep monitoring devices. According to IQ4I research, MRI accounted for the largest revenue in 2019 due to MRI is a premium and sensitive imaging test for brain imaging, used in routine clinical practice. EEG segment is expected to grow at high single digit CAGR from 2019 to 2026.

The electroencephalography devices market is further segmented into 8-Channel EEG, 21-Channel EEG, 25-Channel EEG, 32-Channel EEG, 40-Channel EEG, and multi-channel EEG based on the number of channels. Among them, the 32-Channel EEG devices segment contributed the largest revenue in 2019 and is expected to grow at a strong double digit CAGR from 2019 to 2026. Increasing incidence of neurological diseases, increasing demand by neurologists and patients for advanced monitoring techniques are the factors driving the market growth.

The MRI devices market is further segmented into Low and middle field MRI, High-field MRI, and Very high field MRI based on technology. Among these, the high field MRI devices contributed the largest revenue in 2019 and are expected to grow at mid single digit CAGR from 2019 to 2026 due to accuracy and efficiency to offer a spatial resolution. Very high field MRI is expected to grow at a high single digit CAGR from 2019 to 2026.

The CT devices market is segmented into Low slice CT, Medium slice CT and High slice CT based on technology. Among the segments, medium slice CT devices generated the largest revenue in 2019 and are expected to grow at a mid single digit CAGR from 2019 to 2026. High slice CT is expected to grow at high single digit CAGR from 2019 to 2026 due to the rising adoption of CT for diagnostic procedures and the expanded application horizons of CT technology.

The brain monitoring devices market is further segmented into neurodegenerative disorders, neurovascular diseases, Traumatic brain injury, brain tumor, sleep disorders, psychiatric behavioral disorders, and others based on application. Among these, Sleep disorders accounted for the largest revenue in 2019 and are expected to grow at a CAGR of low single digit from 2019 to 2026. Traumatic brain injury is expected to grow at a high single digit CAGR from 2019 to 2026 due to the growing incidence of TBI’s across the globe due to rise in accidence cases, leading to the high demand for the management of these cases-which requires the intensive use of brain monitoring devices.

Neurodegenerative disorders are further segmented into Alzheimer’s, Parkinson’s disease, Epilepsy, and others (Huntington’s disease) based on diseases. Among these, Epilepsy accounted for the largest revenue in 2019. Alzheimer’s is expected to grow at a mid single digit CAGR from 2019 to 2026.

Sleep disorders are further segmented into insomnia, sleep apnea, sleep movement disorders, and others (hypersomnia). Among these, Sleep apnea accounted for the largest revenue in 2019 and is expected to grow at a mid single digit CAGR from 2019 to 2026.

Psychiatric behavioral disorders are further segmented into Schizophrenia, Bipolar disorders, and others (Depression, Autism & Dyslexia). Among these, Schizophrenia accounted for the largest revenue in 2019 and bipolar disorder is expected to grow at mid single digit CAGR from 2019 to 2026.

Other applications are further segmented into surgery, hydrocephalus, and others. Among these, surgery accounted for the largest revenue in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2026.

The brain monitoring devices segmented into stationary, portable, and wearable based on portability. Among these, stationary accounted for the largest revenue in 2019 and is expected to grow at a mid single digit CAGR from 2019 to 2026. The portable segment is expected to grow at mid single digit CAGR 2019 to 2026.

The brain monitoring devices market based on end-user is segmented into hospitals, home care, ambulatory surgical centers and clinics, diagnostic laboratories, sleep centers, and others. Among these, the hospitals are accounted for the largest revenue in 2019 and are expected to grow at mid single digit CAGR from 2019 to 2026.

The brain monitoring devices market based on region is segmented into North-America, Europe, APAC and the Rest of the world. North America accounted for the largest revenue in 2019 and is expected to grow at a mid single digit CAGR from 2019 to 2026. APAC is expected to grow at high single digit CAGR from 2019 to 2026.

Major players in brain monitoring device market are Medtronic, PLC (Ireland), Integra Lifesciences (U.S.), Masimo Corporation (Switzerland), GE Healthcare (U.S.), Koninklijke Philips N.V. (The Netherlands), Nihon Kohden Corporation (Japan), Natus medical Incorporated (U.S.), Siemens Healthineers (Germany), Resmed, Inc. (U.S.) and Vyaire Medical, Inc. (U.S.).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

North America (U.S. and Rest of N.A.)
Europe (Germany, France, U.K. and Rest of E.U.)
Asia-Pacific (Japan, China, India and Rest of APAC)
Rest of the World (RoW) (Brazil, Rest of Latin-America and the Middle East & Others)

1 EXECUTIVE SUMMARY
2 INTRODUCTION

2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY

2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS

3 MARKET ANALYSIS

3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET

3.3.1 DRIVERS AND OPPORTUNITIES

3.3.1.1 GROWING INCIDENCE AND PREVALENCE OF NEUROLOGICAL DISORDERS
3.3.1.2 RISING AWARENESS ABOUT NEURODEGENERATIVE DISORDERS
3.3.1.3 GROWING HEALTHCARE SPENDING
3.3.1.4 TECHNOLOGICAL ADVANCEMENTS IN BRAIN MONITORING DEVICES
3.3.1.5 INCREASING FOCUS ON MINIMALLY INVASIVE AND NON-INVASIVE BRAIN ACTIVITY MONITORING PROCEDURES
3.3.1.6 EXTENDED APPLICATION OF DEVICES IN CLINICAL TRIALS

3.3.2 RESTRAINTS & THREATS

3.3.2.1 THE HIGH COST OF COMPLEX DEVICES
3.3.2.2 LACK OF SKILLED NEUROLOGISTS & NEUROSURGEONS
3.3.2.3 STRINGENT REGULATIONS AND LEGISLATIONS GUIDING THE BRAIN MONITORING DEVICE MANUFACTURERS
3.3.2.4 UNFAVORABLE REIMBURSEMENT POLICIES

3.4 MARKET SHARE ANALYSIS

3.4.1 BRAIN MONITORING MARKET SHARE ANALYSIS
3.4.2 EEG MARKET SHARE ANALYSIS
3.4.3 ICP MARKET SHARE ANALYSIS
3.4.4 TCD MARKET SHARE ANALYSIS
3.4.5 PSG MARKET SHARE ANALYSIS
3.4.6 CEREBRAL OXIMETER MARKET SHARE ANALYSIS

3.5 REGULATORY AFFAIRS

3.5.1 THE U.S.
3.5.2 EUROPE
3.5.3 CHINA
3.5.4 INDIA
3.5.5 JAPAN

3.6 TECHNOLOGICAL ADVANCEMENTS

3.6.1 DISSOLVABLE BRAIN IMPLANTS
3.6.2 DIFFUSED OPTICAL TOMOGRAPHY
3.6.3 ARTIFICIAL INTELLIGENCE
3.6.4 EAR ENCEPHALOGRAPHY (EAR-EEG)
3.6.5 FUNCTIONAL NEAR-INFRARED SPECTROSCOPY (FNIRS)
3.6.6 INTRACRANIAL ELECTROENCEPHLAOGRAPHY (IEEG)OR ECOG
3.6.7 MULTI-ELECTRODE ARRAY (MEA)
3.6.8 DIFFUSION TENSOR IMAGING TRACTOGRAPHY (DTI TRACTOGRAPHY)

3.7 BRAIN MONITORING-FUNDING SCENARIO
3.8 BRAIN MONITORING DEVICES – DEALS, APPROVALS, AND NEW PRODUCT LAUNCH
3.9 BRAIN MONITORING DEVICES-ACQUISITION
3.10 BRAIN MONITORING DEVICES-DEALS
3.11 APPROVAL
3.12 PORTER’S FIVE FORCE ANALYSIS

3.12.1 THREAT OF NEW ENTRANTS
3.12.2 THREAT OF SUBSTITUTES
3.12.3 RIVALRY AMONG EXISTING COMPETITORS
3.12.4 BARGAINING POWER OF SUPPLIERS
3.12.5 BARGAINING POWER OF BUYERS

3.13 PATENT ANALYSIS
3.14 UNITS SOLD OF BRAIN MONITORING DEVICES

3.14.1 EEG DEVICES UNITS SOLD
3.14.2 ICP DEVICES UNITS SOLD
3.14.3 EMG DEVICES UNITS SOLD
3.14.4 CEREBRAL OXIMETER DEVICES UNITS SOLD
3.14.5 TCD DEVICES UNITS SOLD
3.14.6 PSG DEVICES UNITS SOLD

3.15 INSTALLED BASE OF BRAIN MONITORING DEVICES

3.15.1 EEG DEVICES INSTALLED BASE
3.15.2 ICP DEVICES INSTALLED BASE
3.15.3 EMG DEVICES INSTALLED BASE
3.15.4 CEREBRAL OXIMETER DEVICES INSTALLED BASE
3.15.5 TCD DEVICES INSTALLED BASE
3.15.6 PSG DEVICES INSTALLED BASE

4 BRAIN MONITORING DEVICES MARKET, BY PRODUCTS

4.1 INTRODUCTION
4.2 ELECTROENCEPHALOGRAPHY (EEG) DEVICES

4.2.1 BY PRODUCTS

4.2.1.1 8-CHANNEL EEG
4.2.1.2 21-CHANNEL EEG
4.2.1.3 25-CHANNEL EEG
4.2.1.4 32-CHANNEL EEG
4.2.1.5 40-CHANNEL EEG
4.2.1.6 MULTI-CHANNEL EEG

4.3 MAGNETOENCEPHALOGRAPHY (MEG) DEVICES
4.4 INTRACRANIAL PRESSURE (ICP) MONITORS
4.5 TRANSCRANIAL DOPPLER DEVICES
4.6 ELECTROMYOGRAPH MACHINES (EMG)
4.7 CEREBRAL OXIMETERS
4.8 MAGNETIC RESONANCE IMAGING (MRI) DEVICES

4.8.1 BY TECHNOLOGY

4.8.1.1 LOW AND MIDDLE FIELD MRI
4.8.1.2 HIGH FIELD MRI
4.8.1.3 VERY HIGH FIELD MRI

4.9 COMPUTERIZED TOMOGRAPHY (CT) DEVICES

4.9.1 BY TECHNOLOGY

4.9.1.1 LOW SLICE CT
4.9.1.2 MEDIUM SLICE CT
4.9.1.3 HIGH SLICE CT

4.10 POSITRON EMISSION TOMOGRAPHY (PET) DEVICES
4.11 SLEEP MONITORING DEVICES
4.12 OTHERS

5 BRAIN MONITORING DEVICES GLOBAL MARKET, BY APPLICATIONS

5.1 INTRODUCTION
5.2 NEURODEGENERATIVE DISORDERS

5.2.1 ALZHEIMER’S DISEASE (DEMENTIA)
5.2.2 PARKINSON’S DISEASE
5.2.3 EPILEPSY
5.2.4 OTHERS (HUNTINGTON’S DISEASE)
5.2.5 NEUROVASCULAR DISEASE

5.3 BRAIN TUMOR
5.4 SLEEP DISORDERS

5.4.1 INSOMNIA
5.4.2 SLEEP APNEA
5.4.3 SLEEP MOVEMENT DISORDERS
5.4.4 OTHERS (HYPERSOMNIA)

5.5 PSYCHIATRIC BEHAVIORAL DISORDERS

5.5.1 SCHIZOPHRENIA
5.5.2 BIPOLAR DISORDERS
5.5.3 OTHERS

5.6 OTHER APPLICATIONS

5.6.1 SURGERY
5.6.2 HYDROCEPHALUS
5.6.3 OTHERS

6 BRAIN MONITORING DEVICES MARKET, BY MODALITY

6.1 INTRODUCTION
6.2 STATIONARY BRAIN MONITORING DEVICES
6.3 PORTABLE BRAIN MONITORING DEVICES
6.4 WEARABLE BRAIN MONITORING DEVICES

7 BRAIN MONITORING DEVICES GLOBAL MARKET, BY END-USERS

7.1 INTRODUCTION
7.2 HOSPITALS
7.3 HOME CARE
7.4 AMBULATORY SURGICAL CENTERS AND CLINICS
7.5 DIAGNOSTIC LABORATORIES
7.6 SLEEP CENTERS
7.7 OTHER END-USERS

8 BRAIN MONITORING DEVICES MARKET BY REGION

8.1 INTRODUCTION
8.2 NORTH AMERICA

8.2.1 THE U.S.
8.2.2 REST OF NORTH AMERICA

8.3 EUROPE

8.3.1 GERMANY
8.3.2 FRANCE
8.3.3 U.K
8.3.4 REST OF EUROPE

8.4 APAC

8.4.1 JAPAN
8.4.2 CHINA
8.4.3 INDIA
8.4.4 REST OF APAC

8.5 ROW

8.5.1 BRAZIL
8.5.2 REST OF LATAM
8.5.3 MIDDLE EAST AND OTHERS

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION
9.2 COLLABORATION, AGREEMENTS, AND PARTNERSHIPS
9.3 APPROVALS
9.4 NEW PRODUCT LAUNCH
9.5 OTHER DEVELOPMENTS

10 MAJOR PLAYER PROFILES

10.1 GE COMPANY

10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS

10.2 INTEGRA LIFESCIENCES HOLDINGS CORPORATION

10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS

10.3 KONINKLIJKE PHILIPS N.V.

10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS

10.4 MASIMO CORPORATION

10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS

10.5 MEDTRONIC, PLC

10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS

10.6 NATUS MEDICAL INC.ORPORATED.

10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS

10.7 NIHON KOHEDEN CORPORATION.

10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS

10.8 RESMED INC.

10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS

10.9 SIEMENS HEALTHINEERS

10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS

10.10 VYAIRE MEDICAL, INC.

10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS

LIST OF TABLES

TABLE 1 BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 2 EEG DEVICES UNITS SOLD, BY REGION, (2018-2026) (NO’S)
TABLE 3 ICP DEVICES UNITS SOLD, BY REGION, (2018-2026) (NO’S)
TABLE 4 EMG DEVICES UNITS SOLD, BY REGION, (2018-2026) (NO’S)
TABLE 5 CEREBRAL OXIMETER DEVICES UNITS SOLD, BY REGION, (2018-2026) (NO’S)
TABLE 6 TCD DEVICES UNITS SOLD, BY REGION, (2018-2026) (NO’S)
TABLE 7 PSG DEVICES UNITS SOLD, BY REGION, (2018-2026) (NO’S)
TABLE 8 EEG DEVICES GLOBAL INSTALLED BASE, BY REGION, (2018-2026) (NO’S)
TABLE 9 ICP DEVICES INSTALLED BASE, BY REGION, (2018-2026) (NO’S)
TABLE 10 EMG DEVICES INSTALLED BASE, BY REGION, (2018-2026) (NO’S)
TABLE 11 CEREBRAL OXIMETER DEVICES INSTALLED BASE, BY REGION, (2018-2026) (NO’S)
TABLE 12 TCD DEVICES INSTALLED BASE, BY REGION, (2018-2026) (NO’S)
TABLE 13 PSG DEVICES INSTALLED BASE, BY REGION, (2018-2026) (NO’S)
TABLE 14 BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 15 EEG DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 16 EEG DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 17 8-CHANNEL EEG DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 18 21-CHANNEL EEG DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 19 25-CHANNEL EEG DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 20 32-CHANNEL EEG DEVICES GLOBAL MARKET REVENUE, BY REGION,
TABLE 21 40-CHANNEL EEG DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 22 MULTI-CHANNEL EEG DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 23 MEG DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 24 ICP DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 25 TCD DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 26 EMG GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 27 CEREBRAL OXIMETERS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 28 MRI DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 29 MRI DEVICES GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2018-2026) ($MN)
TABLE 30 LOW AND MIDDLE FIELD MRI DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 31 HIGH FIELD MRI DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 32 VERY HIGH FIELD MRI DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 33 CT DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 34 CT DEVICES GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2018-2026) ($MN)
TABLE 35 LOW SLICE CT DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 36 MEDIUM SLICE CT DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 37 HIGH SLICE CT DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 38 PET DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 39 SLEEP MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 40 OTHER BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 41 BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 42 NEURODEGENERATIVE DISORDERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 43 NEURODEGENERATIVE DISORDERS GLOBAL MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 44 ALZHEIMER’S GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 45 PARKINSON’S DISEASE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 46 EPILEPSY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 47 OTHERS (HUNTINGTON’S) GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 48 NEUROVASCULAR DISEASES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 49 TRAUMATIC BRAIN INJURY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 50 BRAIN TUMOR GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 51 SLEEP DISORDERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 52 SLEEP DISORDERS GLOBAL MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 53 INSOMNIA GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 54 SLEEP APNEA GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 55 SLEEP MOVEMENT DISORDERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 56 OTHERS (HYPERSOMNIA) GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 57 PSYCHIATRIC AND BEHAVIORAL DISORDERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 58 PSYCHIATRIC AND BEHAVIORAL DISORDERS GLOBAL MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 59 SCHIZOPHRENIA GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 60 BIPOLAR DISORDERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 61 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 62 OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 63 OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 64 SURGERY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 65 HYDROCEPHALUS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 66 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 67 BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY MODALITY, (2018-2026) ($MN)
TABLE 68 STATIONARY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 69 PORTABLE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 70 WEARABLE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 71 BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2018-2026) ($MN)
TABLE 72 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 73 HOMECARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 74 AMBULATORY SURGICAL CENTERS AND CLINIC GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 75 DIAGNOSTIC LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 76 SLEEP CENTERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 77 OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 78 BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 79 NORTH AMERICA BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 80 NORTH AMERICA EEG MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 81 NORTH AMERICA MRI DEVICES MARKET REVENUE, BY TECHNOLOGY, (2018-2026) ($MN)
TABLE 82 NORTH AMERICA CT MARKET REVENUE, BY TECHNOLOGY, (2018-2026) ($MN)
TABLE 83 NORTH AMERICA BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 84 NORTH AMERICA NEURODEGENERATIVE DISORDERS MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 85 NORTH AMERICA SLEEP DISORDERS MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 86 NORTH AMERICA PSYCHIATRIC & BEHAVIORAL DISORDERS MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 87 NORTH AMERICA OTHER APPLICATIONS MARKET REVENUE, BY CONDITION, (2018-2026) ($MN)
TABLE 88 NORTH AMERICA BRAIN MONITORING DEVICES MARKET REVENUE, BY MODALITY, (2018-2026) ($MN)
TABLE 89 NORTH AMERICA BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS, (2018-2026) ($MN)
TABLE 90 NORTH AMERICA BRAIN MONITORING DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 91 EUROPE BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 92 EUROPE EEG DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 93 EUROPE MRI DEVICES MARKET REVENUE, BY TECHNOLOGY, (2018-2026) ($MN)
TABLE 94 EUROPE CT MARKET REVENUE, BY TECHNOLOGY, (2018-2026) ($MN)
TABLE 95 EUROPE BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 96 EUROPE NEURODEGENERATIVE DISORDERS MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 97 EUROPE SLEEP DISORDERS MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 98 EUROPE PSYCHIATRIC AND BEHAVIORAL DISORDERS MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 99 EUROPE OTHER APPLICATIONS MARKET REVENUE BY CONDITION, (2018-2026) ($MN)
TABLE 100 EUROPE BRAIN MONITORING DEVICES MARKET REVENUE BY MODALITY, (2018-2026) ($MN)
TABLE 101 EUROPE BRAIN MONITORING DEVICES MARKET REVENUE BY COUNTRY, (2018-2026) ($MN)
TABLE 102 APAC BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 103 APAC EEG DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 104 APAC MRI DEVICES MARKET REVENUE, BY TECHNOLOGY, (2018-2026) ($MN)
TABLE 105 APAC CT DEVICES MARKET REVENUE, BY TECHNOLOGY, (2018-2026) ($MN)
TABLE 106 APAC BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 107 APAC NEURODEGENERATIVE DISORDERS MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 108 APAC SLEEP DISORDERS MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 109 APAC PSYCHIATRIC & BEHAVIORAL DISORDERS MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 110 APAC OTHER APPLICATIONS MARKET REVENUE BY CONDITION, (2018-2026) ($MN)
TABLE 111 APAC BRAIN MONITORING DEVICES MARKET REVENUE BY MODALITY, (2018-2026) ($MN)
TABLE 112 APAC BRAIN MONITORING DEVICES MARKET REVENUE BY END-USERS, (2018-2026) ($MN)
TABLE 113 APAC BRAIN MONITORING DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 114 ROW BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 115 ROW EEG DEVICES MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 116 ROW MRI DEVICES MARKET REVENUE, BY TECHNOLOGY, (2018-2026) ($MN)
TABLE 117 ROW CT DEVICES MARKET REVENUE, BY TECHNOLOGY, (2018-2026) ($MN)
TABLE 118 ROW BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS, (2018-2026) ($MN)
TABLE 119 ROW NEURODEGENERATIVE DISORDERS MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 120 ROW SLEEP DISORDERS MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 121 ROW PSYCHIATRIC AND BEHAVIORAL DISORDERS MARKET REVENUE, BY DISEASE, (2018-2026) ($MN)
TABLE 122 ROW OTHER APPLICATIONS MARKET REVENUE BY CONDITION, (2018-2026) ($MN)
TABLE 123 ROW BRAIN MONITORING DEVICES MARKET REVENUE BY MODALITY, (2018-2026) ($MN)
TABLE 124 ROW BRAIN MONITORING DEVICES MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 125 APPROVALS
TABLE 126 NEW PRODUCT LAUNCH
TABLE 127 OTHER DEVELOPMENTS
TABLE 128 GE COMPANY: TOTAL REVENUE AND R&D EXPENSES (2017 – 2019) ($MN)
TABLE 129 GE COMPANY: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
TABLE 130 GE COMPANY: TOTAL REVENUE, BY HEALTHCARE SEGMENT (2017 –2019) ($MN)
TABLE 131 GE COMPANY: TOTAL REVENUE, BY GEOGRAPHY (2017 –2019) ($MN)
TABLE 132 INTEGRA LIFESCIENCES: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 133 INTEGRA LIFESCIENCES: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
TABLE 134 INTEGRA LIFESCIENCES: TOTAL REVENUE, BY SUB-SEGMENTS, (2017-2019) ($MN)
TABLE 135 INTEGRA LIFESCIENCES: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 136 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 137 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
TABLE 138 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 139 MASIMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
TABLE 140 MASIMO CORPORATION: TOTAL REVENUE, BY REGIONS (2017-2019) ($MN)
TABLE 141 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q3) ($MN)
TABLE 142 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2017-2019) (Q3) ($MN)
TABLE 143 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) (Q3) ($MN)
TABLE 144 NATUS MEDICAL INC.ORPORATED: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
TABLE 145 NATUS MEDICAL CORPORATION: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
TABLE 146 NATUS MEDICAL CORPORATION: TOTAL REVENUE, BY SUB-SEGMENT (2017-2019)($MN)
TABLE 147 NATUS MEDICAL CORPORATION: TOTAL REVENUE, BY REGION (2017-2019)($MN)
TABLE 148 NIHON KOHDEN: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
TABLE 149 NIHON KOHDEN: TOTAL REVENUE, BY BUSINESS SEGMENTS (2017-2019)($MN)
TABLE 150 NIHON KOHDEN: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) ($MN)
TABLE 151 RESMED INC.: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) (Q2) ($MN)
TABLE 152 RESMED INC.: TOTAL REVENUE, BY SEGMENT, (2018-2020) (Q2) ($MN)
TABLE 153 RESMED INC.: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) (Q2) ($MN)
TABLE 154 SIEMENS HEALTHINEERS: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) (Q2) ($MN)
TABLE 155 SIEMENS HEALTHINEERS: TOTAL REVENUE, BY SEGMENT, (2018-2020) (Q2) ($MN)
TABLE 156 SIEMENS HEALTHINEERS: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) (Q2) ($MN)

LIST OF FIGURES

FIGURE 1 BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: BRAIN MONITORING DEVICES GLOBAL MARKET
FIGURE 3 BRAIN MONITORING DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 BRAIN MONITORING DEVICES GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 BRAIN MONITORING DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 BRAIN MONITORING DEVICES GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 BRAIN MONITORING MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 9 EEG MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 10 ICP MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 11 TCD MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 12 PSG MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 13 CEREBRAL OXIMETER MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 14 BRAIN MONITORING DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 15 BRAIN MONITORING DEVICES GLOBAL MARKET: PATENT FILING, BY MAJOR PLAYERS (2015-2019)
FIGURE 16 EEG DEVICES UNITS SOLD, BY REGION AND COUNTRYWISE (2019) (NO’S)
FIGURE 17 ICP DEVICES UNITS SOLD, BY REGION AND COUNTRYWISE (2019) (NO’S)
FIGURE 18 EMG DEVICES UNITS SOLD, BY REGION AND COUNTRYWISE (2019) (NO’S)
FIGURE 19 CEREBRAL OXIMETER DEVICES UNITS SOLD, BY REGION AND COUNTRYWISE (2019) (NO’S)
FIGURE 20 TCD DEVICES UNITS SOLD, BY REGION AND COUNTRYWISE (2019) (NO’S)
FIGURE 21 PSG DEVICES UNITS SOLD, BY REGION AND COUNTRYWISE (2019) (NO’S)
FIGURE 22 EEG DEVICES INSTALLED BASE, BY REGION AND COUNTRYWISE (2019) (NO’S)
FIGURE 23 ICP DEVICES INSTALLED BASE, BY REGION AND COUNTRYWISE (2019) (NO’S)
FIGURE 24 EMG DEVICES INSTALLED BASE, BY REGION AND COUNTRYWISE (2019) (NO’S)
FIGURE 25 CEREBRAL OXIMETER DEVICES INSTALLED BASE, BY REGION AND COUNTRYWISE (2019) (NO’S)
FIGURE 26 TCD DEVICES INSTALLED BASE, BY REGION AND COUNTRYWISE (2019) (NO’S)
FIGURE 27 PSG DEVICES INSTALLED BASE, BY REGION AND COUNTRYWISE (2019) (NO’S)
FIGURE 28 BRAIN MONITORING DEVICES GLOBAL MARKET SHARE, BY PRODUCTS (2019) (%)
FIGURE 29 EEG DEVICES GLOBAL MARKET SHARE, BY PRODUCTS (2019 VS 2026) (%)
FIGURE 30 25-CHANNEL EEG DEVICES GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 31 40-CHANNEL EEG DEVICES GLOBAL MARKET SHARE, BY REGION
FIGURE 32 MRI DEVICES GLOBAL MARKET SHARE, BY TECHNOLOGY (2019 VS 2026) (%)
FIGURE 33 LOW & MIDDLE FIELD MRI DEVICES GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 34 HIGH FIELD MRI DEVICES GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 35 VERY HIGH FIELD MRI DEVICES GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 36 CT DEVICES GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 37 CT DEVICES GLOBAL MARKET SHARE, BY TECHNOLOGY (2019 VS 2026) (%)
FIGURE 38 LOW SLICE CT DEVICES GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 39 MEDIUM SLICE CT DEVICES GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 40 HIGH SLICE CT DEVICES GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 41 PET DEVICES GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 42 BRAIN MONITORING DEVICES GLOBAL MARKET SHARE, BY APPLICATIONS (2019 VS 2026) (%)
FIGURE 43 NEURODEGENERATIVE DISORDERS GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 44 NEURODEGENERATIVE DISORDER GLOBAL MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 45 ALZHEIMER’S GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 46 PARKINSON’S GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 47 EPILEPSY’S GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 48 NEUROVASCULAR DISEASES GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 49 TBI GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 50 BRAIN TUMOR GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 51 SLEEP DISORDERS GLOBAL MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 52 PSYCHIATRIC & BEHAVIOURAL GLOBAL MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 53 OTHER APPLICATIONS GLOBAL MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 54 BRAIN MONITORING DEVICES GLOBAL MARKET SHARE, BY MODALITY (2019 VS 2026) (%)
FIGURE 55 STATIONARY DEVICES GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 56 PORTABLE DEVICES GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 57 BRAIN MONITORING DEVICES GLOBAL MARKET SHARE, BY END-USERS (2019 VS 2026) (%)
FIGURE 58 HOSPITALS GLOBAL MARKET SHARE, BY REGION (2019 VS 2025) (%)
FIGURE 59 HOME CARE GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 60 DIAGNOSTIC LABORATORIES GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 61 OTHER END-USERS GLOBAL MARKET SHARE, BY REGION (2019 VS 2026) (%)
FIGURE 62 BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN), CAGR (%)
FIGURE 63 BRAIN MONITORING DEVICES GLOBAL MARKET SHARE BY REGION AND MARKET REVENUE BY COUNTRY, (2019) (%) ($MN)
FIGURE 64 NORTH AMERICA BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2019) (%)
FIGURE 65 NORTH AMERICA EEG MARKET SHARE, BY PRODUCTS (2019 VS 2026) (%)
FIGURE 66 NORTH AMERICA MRI MARKET SHARE, BY TECHNOLOGY (2019 VS 2026) (%)
FIGURE 67 NORTH AMERICA CT MARKET SHARE, BY TECHNOLOGY (2019 VS 2026) (%)
FIGURE 68 NORTH AMERICA BRAIN MONITORING DEVICES MARKET SHARE, BY APPLICATIONS (2019 VS 2026) (%)
FIGURE 69 NORTH AMERICA NEURODEGENERATIVE DISORDERS MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 70 NORTH AMERICA SLEEP DISORDERS MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 71 NORTH AMERICA PSYCHIATRIC & BEHAVIORAL DISORDERS MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 72 NORTH-AMERICA OTHER APPLICATIONS MARKET SHARE, BY CONDITION (2019 VS 2026) (%)
FIGURE 73 NORTH AMERICA BRAIN MONITORING DEVICES MARKET SHARE, BY MODALITY (2019 VS 2026) (%)
FIGURE 74 NORTH-AMERICA BRAIN MONITORING DEVICES MARKET SHARE, BY END-USERS (2019 VS 2026) (%)
FIGURE 75 NORTH AMERICA BRAIN MONITORING DEVICES MARKET SHARE, BY COUNTRY (2019 VS 2026) (%)
FIGURE 76 U.S. BRAIN MONITORING MARKET REVENUE, BY PRODUCTS, (2019) ($MN)
FIGURE 77 U.S. BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS (2019 VS 2026) ($MN)
FIGURE 78 U.S. BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY END-USERS, BY MODALITY (2019 VS 2026) ($MN)
FIGURE 79 REST OF N.A. BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2019) ($MN)
FIGURE 80 REST OF N.A. BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS (2019 VS 2026) ($MN)
FIGURE 81 REST OF N.A. BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS, BY MODALITY (2019 VS 2026) ($MN)
FIGURE 82 EUROPE BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2019) (%)
FIGURE 83 EUROPE EEG DEVICES MARKET SHARE, BY PRODUCTS (2019 VS 2026) (%)
FIGURE 84 EUROPE MRI MARKET SHARE, BY TECHNOLOGY (2019 VS 2026) (%)
FIGURE 85 EUROPE CT DEVICES MARKET SHARE, BY TECHNOLOGY (2019 VS 2026) (%)
FIGURE 86 EUROPE BRAIN MONITORING DEVICES MARKET SHARE, BY APPLICATIONS (2019 VS 2026) (%)
FIGURE 87 EUROPE NEURODEGENERATIVE DISORDERS MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 88 EUROPE SLEEP DISORDERS MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 89 EUROPE PSYCHIATRIC AND BEHAVIORAL DISORDERS MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 90 EUROPE OTHER APPLICATIONS MARKET SHARE, BY CONDITION (2019 VS 2026) (%)
FIGURE 91 EUROPE BRAIN MONITORING DEVICES MARKET SHARE, BY MODALITY (2019 VS 2026) (%)
FIGURE 92 EUROPE BRAIN MONITORING DEVICES MARKET REVENUE BY END-USERS, (2018-2026) ($MN)
FIGURE 93 EUROPE BRAIN MONITORING DEVICES MARKET SHARE, BY END-USERS (2019 VS 2026) (%)
FIGURE 94 EUROPE BRAIN MONITORING DEVICES MARKET SHARE, BY COUNTRY (2019 VS 2026) (%)
FIGURE 95 GERMANY BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2019) ($MN)
FIGURE 96 GERMANY BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS (2019 VS 2026) ($MN)
FIGURE 97 GERMANY BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS, BY MODALITY (2019 VS 2026) ($MN)
FIGURE 98 FRANCE BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2019 VS 2026) ($MN)
FIGURE 99 FRANCE BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS (2019 VS 2026) ($MN)
FIGURE 100 FRANCE BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS, BY MODALITY (2019 VS 2026) ($MN)
FIGURE 101 U.K. BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2019) ($MN)
FIGURE 102 U.K. BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS (2019 VS 2026) ($MN)
FIGURE 103 U.K. BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS, BY MODALITY (2019 VS 2026) ($MN)
FIGURE 104 REST OF E.U. BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2019) ($MN)
FIGURE 105 REST OF E.U. BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS (2019 VS 2026) ($MN)
FIGURE 106 REST OF E.U. BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY END-USERS, BY MODALITY (2019 VS 2026) (%)
FIGURE 107 APAC BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2019) (%)
FIGURE 108 APAC EEG DEVICES MARKET SHARE, BY PRODUCTS (2019 VS 2026) (%)
FIGURE 109 APAC MRI DEVICES MARKET SHARE, BY TECHNOLOGY (2019 VS 2026) (%)
FIGURE 110 APAC CT DEVICES MARKET SHARE, BY TECHNOLOGY (2019 VS 2026) (%)
FIGURE 111 APAC BRAIN MONITORING DEVICES MARKET SHARE, BY APPLICATIONS (2019 VS 2026) (%)
FIGURE 112 APAC NEURODEGENERATIVE DISORDERS MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 113 APAC SLEEP DISORDERS MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 114 APAC PSYCHIATRIC AND BEHAVIORAL MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 115 APAC OTHER APPLICATIONS MARKET SHARE, BY CONDITION (2019 VS 2026) (%)
FIGURE 116 APAC BRAIN MONITORING DEVICES MARKET REVENUE, BY MODALITY (2019 VS 2026) (%)
FIGURE 117 APAC BRAIN MONITORING DEVICES MARKET SHARE, BY APPLICATIONS (2019 VS 2026) (%)
FIGURE 118 APAC BRAIN MONITORING DEVICES MARKET SHARE, BY COUNTRY (2019 VS 2026) (%)
FIGURE 119 JAPAN BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2019) ($MN)
FIGURE 120 JAPAN BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS (2019 VS 2026) ($MN)
FIGURE 121 JAPAN BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS AND BY MODALITY (2019 VS 2026) ($MN)
FIGURE 122 CHINA BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2019) ($MN)
FIGURE 123 CHINA BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS (2019 VS 2026) ($MN)
FIGURE 124 CHINA BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS, BY MODALITY (2019 VS 2026) ($MN)
FIGURE 125 INDIA BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2019) ($MN)
FIGURE 126 INDIA BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS (2019 VS 2026) ($MN)
FIGURE 127 INDIA BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS, BY MODALITY (2019 VS 2026) ($MN)
FIGURE 128 REST OF APAC BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2019) ($MN)
FIGURE 129 REST OF APAC BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS (2019 VS 2026) ($MN)
FIGURE 130 REST OF APAC BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS, BY MODALITY (2019 VS 2026) ($MN)
FIGURE 131 ROW BRAIN MONITORING DEVICES MARKET SHARE, BY PRODUCTS (2019) (%)
FIGURE 132 ROW EEG DEVICES MARKET SHARE, BY PRODUCTS (2019 VS 2026) (%)
FIGURE 133 ROW MRI DEVICES MARKET SHARE, BY TECHNOLOGY (2019 VS 2026) (%)
FIGURE 134 ROW CT DEVICES MARKET SHARE, BY TECHNOLOGY (2019 VS 2026) (%)
FIGURE 135 ROW BRAIN MONITORING DEVICES MARKET SHARE, BY APPLICATIONS (2019 VS 2026) (%)
FIGURE 136 ROW NEURODEGENERATIVE DISORDERS MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 137 ROW SLEEP DISORDERS MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 138 ROW PSYCHIATRIC AND BEHAVIORAL MARKET SHARE, BY DISEASE (2019 VS 2026) (%)
FIGURE 139 ROW OTHER APPLICATIONS MARKET SHARE, BY CONDITION (2019 VS 2026) (%)
FIGURE 140 ROW BRAIN MONITORING DEVICES MARKET REVENUE, BY MODALITY (2019 VS 2026) ($MN)
FIGURE 141 ROW BRAIN MONITORING DEVICES MARKET REVENUE BY END-USERS, (2018-2026) ($MN)
FIGURE 142 ROW BRAIN MONITORING DEVICES MARKET SHARE, BY END-USERS (2019 VS 2026) (%)
FIGURE 143 ROW BRAIN MONITORING DEVICES MARKET SHARE, BY COUNTRY (2019 VS 2026) (%)
FIGURE 144 BRAZIL BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2019) ($MN)
FIGURE 145 BRAZIL BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS (2019 VS 2026) ($MN)
FIGURE 146 BRAZIL BRAIN MONITORING DEVICES GLOBAL MARKET REVENUE, BY END-USERS, BY MODALITY (2019 VS 2026) ($MN)
FIGURE 147 REST OF LATIN AMERICA BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2019) ($MN)
FIGURE 148 REST OF LATAM BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS (2019 VS 2026) ($MN)
FIGURE 149 REST OF LATAM BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS, BY MODALITY (2019 VS 2026) ($MN)
FIGURE 150 MIDDLE EAST AND OTHERS BRAIN MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, (2019 VS 2026) ($MN)
FIGURE 151 MIDDLE EAST & OTHERS BRAIN MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS (2019 VS 2026) ($MN)
FIGURE 152 MIDDLE EAST & OTHERS BRAIN MONITORING DEVICES MARKET REVENUE, BY END-USERS, BY MODALITY (2019 VS 2026) ($MN)
FIGURE 153 KEY GROWTH STRATEGIES (2018-2020)
FIGURE 154 SWOT: GE HEALTHCARE
FIGURE 155 SWOT: INTEGRA LIFESCIENCES
FIGURE 156 SWOT: KONINKLIJKE PHILIPS N.V.
FIGURE 157 SWOT: MASIMO CORPORATION
FIGURE 158 SWOT: MEDTRONIC, PLC
FIGURE 159 SWOT: NATUS MEDICAL CORPORATION.
FIGURE 160 SWOT: NIHON KOHDEN.
FIGURE 161 SWOT: RESMED, INC.,
FIGURE 162 SWOT: SIEMENS HEALTHINEERS
FIGURE 163 SWOT: VYAIRE MEDICAL INC.

LIST OF COMPANIES MENTIONED IN THE REPORT

1 ADVANCED BRAIN MONITORING, INC.
2 ALLENGERS MEDICAL SYSTEMS LIMITED
3 ALLTECH MEDICAL SYSTEMS, LLC
4 ANT NEURO
5 ATYS MEDICAL
6 ATYSMEDICAL ATYS
7 BEDDIT OY
8 BITTIUM CORPORATION
9 BMEDICAL
10 BRAINSCOPE COMPANY, INC
11 BRAINTRONICS B.V.
12 CADWELL INDUSTRIES, INC
13 CANON MEDICAL SYSTEMS LTD.
14 CEREBROTECH MEDICAL SYSTEMS, INC.
15 CERIBELL, INC.
16 CLARITY MEDICAL PVT. LTD
17 CLEVEMED MEDICAL DEVICES, INC.
18 CLINICAL SCIENCE SYSTEMS
19 COMPUMEDICS LIMITED
20 CONTEC MEDICAL SYSTEMS
21 CONTEXT VISION, AB
22 CTF MEG INTERNATIONAL SERVICES LP
23 DANTEC DYNAMICS LTD
24 DEYMED DIAGNOSTIC S.R.O
25 DREEM SAS
26 DYMEDIX DIAGNOSTICS, INC.
27 EB NEURO S.P.A
28 EDWARD LIFE SCIENCES
29 ELEKTA AB
30 ELMIKO MEDICAL SP.Z O.O.
31 ELMINDA LIMITED
32 EMS HANDELS GESELLSCHAFT MBH
33 ENCEPHALODYNAMICS, INC.
34 GAELTEC DEVICES LTD
35 GE HEALTHCARE
36 HITACHI LIMITED
37 INTEGRA LIFESCIENCES
38 KONINKLIJKE PHILIPS N.V.
39 LÖWENSTEIN GMBH & CO. KG
40 MAGNETICA LIMITED
41 MASIMO CORPORATION
42 MEDASENSE BIOMETRICS LTD
43 MEDICOM MTD
44 MEDTECH
45 MEDTRONIC, PLC
46 MICROMED S.P.A
47 MITSAR CO. LTD
48 MOBERG RESEARCH
49 MOTION LAB SYSTEMS
50 NATUS MEDICAL INCORPORATED
51 NCC MEDICAL CO., LTD
52 NEMODEVICES AG
53 NEUROCARE GROUP GMBH
54 NEUROELECTRIC
55 NEUROELECTRICS COMPANY
56 NEURONETRIX SOLUTIONS, LLC
57 NEUROSIGN SURGICAL
58 NEUROSOFT
59 NEUROSTYLE PTE LTD
60 NEUROVIRTUAL/SLEEPVIRTUAL
61 NEUROWAVE SYSTEMS, INC.
62 NIHON KOHDEN CORPORATION
63 NONIN MEDICAL, INC
64 NORAXON USA, INC.
65 NOVASIGNAL CORPORATION
66 NOX MEDICAL
67 PAINQX,INC
68 RAUMEDIC AG
69 RECORDERS & MEDICARE SYSTEMS PVT LTD
70 REMED
71 RESMED,INC
72 RHYTHM LINK, LLC
73 RICOH
74 RIMED LIMITED
75 SHENZHEN BASDA MEDICAL APPARATUS CO.,LTD
76 SHENZHEN DELICA MEDICAL EQUIPEMENT CO.，LTD
77 SIEMENS HEALTHINEERS
78 SOMNOMEDICS GMBH
79 SONOMED SP.Z.O.O.
80 SOTERIX MEDICAL, INC.
81 SPIEGELBERG GMBH & CO.KG
82 SYNTHETICMR
83 TIME MEDICAL HOLDING
84 TRISTAN TECHNOLOGIES, INC.
85 UNITED IMAGING HEALTHCARE CO., LTD.
86 VIASONIX LTD
87 VYAIRE MEDICAL, INC
88 WITHINGS
89 WUHAN GREENTEK PTY LTD
90 ZETO, INC.

Brain Monitoring Devices Global Market-Forecast to 2026

LIST OF TABLES

LIST OF FIGURES

LIST OF COMPANIES MENTIONED IN THE REPORT

IQ4I HEALTHCARE REPORTS

about IQ4I

Get in Touch

IQ4I Quality Accredit Certificate

Subscribe to Newsletter

Medical Devices

Brain Monitoring Devices Global Market-Forecast to 2026

Brain Monitoring Devices Global Market-Forecast to 2026

LIST OF TABLES

LIST OF FIGURES

LIST OF COMPANIES MENTIONED IN THE REPORT

IQ4I HEALTHCARE REPORTS